A Cost-Effectiveness Analysis Comparing the Originator Recombinant Human Alfa to their Biosimilars Follitropin Alfa for the Treatment of Infertility
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.699
https://www.valueinhealthjournal.com/article/S1098-3015(17)31033-1/fulltext
Title :
A Cost-Effectiveness Analysis Comparing the Originator Recombinant Human Alfa to their Biosimilars Follitropin Alfa for the Treatment of Infertility
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31033-1&doi=10.1016/j.jval.2017.08.699
First page :
A522
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
666